Prometheus Biosciences Stock Price, News & Analysis
Company Description
Prometheus Biosciences (NASDAQ: RXDX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $9.6B.
RXDX stock has gained 692.7% over the past year.
This page provides a comprehensive overview of RXDX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Prometheus Biosciences (RXDX) stock. Over the past 12 months, the stock has gained 692.7%. At a market capitalization of $9.6B, RXDX is classified as a mid-cap stock with approximately 47.8M shares outstanding.
Latest News
Prometheus Biosciences has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include management, acquisition, earnings, conferences, offering. View all RXDX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RXDX Company Profile & Sector Positioning
Prometheus Biosciences (RXDX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.